Many women breathe a sigh of relief when they test negative for BRCA gene mutations, which raise the risk for breast, ovarian and other cancers. But that's not the end of the hereditary risk story.

Geneticist Michael Berger and his colleagues are conducting research that brings together two related but historically separate fields: tumor sequencing and the study of inherited genetic mutations.

Two large-scale studies provide new data on genes, inherited variations, and de novo mutations associated with autism spectrum disorder (ASD). Some of them are also associated with other neurological ...

Medical oncologist Zsofia Stadler is Clinical Director of MSK’s Clinical Genetics Service. The majority of cancers are caused by random genetic changes and environmental exposures — things like ...

A rare mutation on the BCL6-corepressor gene correlated with worse overall survival in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, allogenic stem cell ...

Researchers found a way to screen cancer-linked gene mutations much more easily and quickly than existing approaches, using a variant of CRISPR genome-editing known as prime editing. Tumors can carry ...

Researchers at the University of Virginia School of Medicine have discovered how a common gene mutation robs people of natural cancer protection. Hao Jiang, of the UVA Cancer Center, and his ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

A new gene-editing technique can be used to correct mutations in muscle stem cells, paving the way for the first potential cell therapy for genetic muscle disorders. The ECRC team led by Professor ...

Researchers discovered an example of convergent evolution in the Peruvian and Tibetan highlander communities. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...